Lynparza (olaparib) - Merck (MSD), AstraZeneca
Lutathera (lutetium Lu 177 dotatate) - Novartis
https://www.sciencedirect.com/science/article/pii/S3051291326002855?via%3Dihub
 
F. Lin 1; J. del Rivero 1; J. Zou 1; I. Shamis 1; L. Lindenberg 1; E. Mena-Gonzalez 1; I. B. Turkbey 1; T. Magee 1; Y. Teng 2; C. Millo 3; P. Herscovitch 3; R. Maass-Moreno 3; S. Adler 1; P. Choyke 1; J. Carrasquillo 1, 4
 
Sep 29, 2026
 
Prev Next